Teva Pharmaceutical Industries Ltd (NYSE:TEVA) has a potential bullish bottom on the stock chart after it surged from $32 to $38. Since that surge (over the last 2 weeks), the stock has slowly faded on lighter volume. In technical analysis, this is called bullish consolidation and usually is the setup prior to another big move higher. With the stock currently trading under $35, investors should be buying here. The upside target is $44.00.




Stock chart bullish retrace on shares of Teva Pharmaceutical